Boston Scientific Corp. BSX

NYS: BSX | ISIN: US1011371077   11/09/2026
42,98 USD (-0,28%)
(-0,28%)   11/09/2026

26 augustus 2026 · Maker van pacemakers Boston Scientific getroffen door cyberaanval · Tijd.be (€)

Boston Scientific, een maker van medische apparatuur, is door een cyberaanval getroffen. Daardoor zijn wereldwijd de activiteiten van het Amerikaanse bedrijf verstoord. De sector krijgt steeds vaker af te rekenen met hackers.

10 augustus 2026 · Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results · Persbericht

30 juli 2026 · Penumbra, Inc. Reports Second Quarter 2026 Financial Results · Persbericht

29 juli 2026 · Boston Scientific announces results for second quarter 2026 · Persbericht

19 mei 2026 · FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints · Persbericht

18 mei 2026 · Boston Scientific enters into $2 billion accelerated share repurchase agreement · Persbericht

18 mei 2026 · Boston Scientific announces strategic investment in MiRus LLC · Persbericht

6 mei 2026 · Penumbra, Inc. Reports First Quarter 2026 Financial Results · Persbericht

4 mei 2026 · Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results · Persbericht

1 mei 2026 · BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

27 april 2026 · Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm · Persbericht

26 april 2026 · Data at Heart Rhythm 2026 highlight key Boston Scientific therapies · Persbericht

24 april 2026 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

22 april 2026 · Boston Scientific announces results for first quarter 2026 · Persbericht

21 april 2026 · BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

17 april 2026 · Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

17 april 2026 · BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

16 april 2026 · INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit · Persbericht

16 april 2026 · INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX · Persbericht

16 april 2026 · BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth: SueWallSt · Persbericht

Mijn selecties